Cleared Traditional

ELECSYS TESTOSTERONE ASSAY (K964889) - FDA 510(k) Clearance

Class I Chemistry device.

K964889 · Boehringer Mannheim Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1997
Decision
102d
Days
Class 1
Risk

K964889 is an FDA 510(k) clearance for the ELECSYS TESTOSTERONE ASSAY. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Boehringer Mannheim Corp. (Concord, US). The FDA issued a Cleared decision on March 18, 1997 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Boehringer Mannheim Corp. devices

Submission Details

510(k) Number K964889 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 1996
Decision Date March 18, 1997
Days to Decision 102 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 88d · This submission: 102d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 32
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K964889.
VIDAS TESTOSTERONE (TES), MODEL 30 418
K021326 · bioMerieux, Inc. · Jul 2002
ACCESS TESTOSTERONE REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 33560, 33565
K001935 · Beckman Coulter, Inc. · Aug 2000
ABBOTT ARCHITECT TESTOSTERONE
K983212 · Abbott Laboratories · Nov 1998
IMMULITE TOTAL TESTOSTERONE
K955870 · Diagnostic Products Corp. · Feb 1996
IMMULITE SHBG (MODIFICATION)
K955440 · Diagnostic Products Corp. · Dec 1995
IMMULITE SHBG
K941797 · Diagnostic Products Corp. · Oct 1994